Thalys Medical Technology Group Corporation. News

Celis (603716) Company Express: SPD orders have once again landed across provinces. It is expected that the company's revenue and net profit will grow at a higher rate starting in 2019

安信證券Jan 2, 2019 00:00

Analysis of Selis (603716): the first-mover advantage of SPD business is expected to be about 50% compound growth rate of net profit in the next three years.

安信證券Dec 4, 2018 00:00

Selis (603716) report comments: half-year performance in line with the expected model to comply with the general trend of health care reform is expected to achieve rapid expansion

安信證券Sep 1, 2018 00:00

Selis (603716) semi-annual report comments: the performance is in line with expectations, waiting for local orders to land.

平安證券Aug 31, 2018 00:00

Selis (603716) quarterly report comments: local layout has landed one after another and follow-up growth is promising.

平安證券May 4, 2018 00:00

Selis (603716) Annual report comments: active layout expansion 2018 performance growth is expected to continue

國金證券Mar 27, 2018 00:00

Selis (603716) Annual report comments: continuous increase in channel layout + landing of new projects to ensure high growth of the company's performance

華金證券Mar 26, 2018 00:00

Selis (603716) Annual report comments: national layout to achieve business expansion, deepening services to improve the quality of profits

平安證券Mar 26, 2018 00:00

Selis (603716) comments: higher-than-expected high growth in the fourth quarter is expected to continue

國金證券Feb 7, 2018 00:00

Selis (603716) comments on matters of the company: new order signing SPD business officially launched

平安證券Feb 2, 2018 00:00

Celis (603716) Review: First SPD Business Order Launched to Expand Business Space

國金證券Feb 1, 2018 00:00

Celis (603716) Company Review: New Contract Launched, Intensive Service Expansion Further

平安證券Jan 8, 2018 00:00

Celis (603716) review: fixed increase received approval to inject new impetus into development

國金證券Dec 22, 2017 00:00

Celis (603716) Company Review: Fixed Increase Approved, Intensive Business Development Capabilities Enhanced

平安證券Nov 20, 2017 00:00

Celis (603716) Review of the Third Quarterly Report: Intensive business operations are stable, and the national distribution is thick and sparse

平安證券Nov 6, 2017 00:00

Celis (603716) Third Quarterly Review: Increased Revenue Under Pressure on the Profit Side

國金證券Nov 3, 2017 00:00

Celis (603716) Semi-Annual Report Review: Intensive Coverage Accelerates Upfront Investment

平安證券Aug 30, 2017 00:00

Celis (603716) Interim Report Review: The scale effect is gradually showing that profitability may improve

長城證券Aug 30, 2017 00:00

Celis (603716) Interim Report: Growth on the profit side below expectations in the early stages is worth tracking

國金證券Aug 30, 2017 00:00

Celis (603716) Company Review: Jiangxi's First Contract Has Been Placed a Step Further in the Pace of National Outreach

平安證券Jun 26, 2017 00:00